Yifan Xinfu Pharmaceutical Co Ltd (002019) — Financial Flexibility Index
Yifan Xinfu Pharmaceutical Co Ltd (002019) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of CN¥224.86 Million (operating CF CN¥40.18 Million minus capex CN¥184.68 Million) represents 0% of total liabilities (CN¥4.40 Billion). Check 002019 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Yifan Xinfu Pharmaceutical Co Ltd Financial Flexibility Index (2003–2025)
Historical Financial Flexibility Index trend for Yifan Xinfu Pharmaceutical Co Ltd across 23 annual periods. See Yifan Xinfu Pharmaceutical Co Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Yifan Xinfu Pharmaceutical Co Ltd (2003–2025)
Year-by-year free cash flow to debt coverage for Yifan Xinfu Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see market value of Yifan Xinfu Pharmaceutical Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.25x | CN¥1.02 Billion | CN¥458.37 Million | CN¥4.13 Billion | ▼ -25.1% |
| 2024 | 0.33x | CN¥1.27 Billion | CN¥640.73 Million | CN¥3.86 Billion | ▲ +25.1% |
| 2023 | 0.26x | CN¥852.67 Million | CN¥348.58 Million | CN¥3.24 Billion | ▼ -12.0% |
| 2022 | 0.30x | CN¥1.01 Billion | CN¥472.07 Million | CN¥3.40 Billion | ▲ +16.0% |
| 2021 | 0.26x | CN¥872.97 Million | CN¥301.23 Million | CN¥3.39 Billion | ▼ -57.8% |
| 2020 | 0.61x | CN¥1.82 Billion | CN¥1.11 Billion | CN¥2.99 Billion | ▲ +9.8% |
| 2019 | 0.56x | CN¥1.80 Billion | CN¥937.24 Million | CN¥3.24 Billion | ▼ -15.5% |
| 2018 | 0.66x | CN¥1.90 Billion | CN¥1.17 Billion | CN¥2.89 Billion | ▼ -19.3% |
| 2017 | 0.82x | CN¥1.62 Billion | CN¥1.13 Billion | CN¥1.99 Billion | ▲ +119.8% |
| 2016 | 0.37x | CN¥1.14 Billion | CN¥855.85 Million | CN¥3.08 Billion | ▼ -0.2% |
| 2015 | 0.37x | CN¥619.11 Million | CN¥401.96 Million | CN¥1.67 Billion | ▲ +28.2% |
| 2014 | 0.29x | CN¥229.24 Million | CN¥139.74 Million | CN¥791.21 Million | ▼ -22.9% |
| 2013 | 0.38x | CN¥108.27 Million | CN¥34.32 Million | CN¥288.20 Million | ▲ +123.7% |
| 2012 | 0.17x | CN¥97.52 Million | CN¥29.88 Million | CN¥580.73 Million | ▲ +149.4% |
| 2011 | 0.07x | CN¥46.92 Million | CN¥-52.82 Million | CN¥696.73 Million | ▼ -79.7% |
| 2010 | 0.33x | CN¥165.50 Million | CN¥-33.82 Million | CN¥497.79 Million | ▼ -64.0% |
| 2009 | 0.92x | CN¥209.88 Million | CN¥58.61 Million | CN¥227.31 Million | ▲ +28.1% |
| 2008 | 0.72x | CN¥205.76 Million | CN¥83.31 Million | CN¥285.39 Million | ▼ -42.4% |
| 2007 | 1.25x | CN¥420.77 Million | CN¥248.71 Million | CN¥335.87 Million | ▲ +271.9% |
| 2006 | 0.34x | CN¥90.24 Million | CN¥32.62 Million | CN¥267.92 Million | ▼ -20.2% |
| 2005 | 0.42x | CN¥82.76 Million | CN¥24.12 Million | CN¥196.02 Million | ▼ -80.2% |
| 2004 | 2.13x | CN¥103.73 Million | CN¥33.59 Million | CN¥48.72 Million | ▲ +242.5% |
| 2003 | 0.62x | CN¥65.09 Million | CN¥12.65 Million | CN¥104.73 Million | — |